Targeting nonapoptotic pathways with functionalized nanoparticles for cancer therapy: Current and future perspectives

M Yadav, K Niveria, T Sen, I Roy, AK Verma - Nanomedicine, 2021 - Taylor & Francis
Apoptotic death evasion is a hallmark of cancer progression. In this context, past decades
have witnessed cytotoxic agents targeting apoptosis. However, owing to cellular defects in …

Targeting nonapoptotic pathways with functionalized nanoparticles for cancer therapy: current and future perspectives.

M Yadav, K Niveria, T Sen, I Roy… - Nanomedicine (London …, 2021 - europepmc.org
Apoptotic death evasion is a hallmark of cancer progression. In this context, past decades
have witnessed cytotoxic agents targeting apoptosis. However, owing to cellular defects in …

Targeting nonapoptotic pathways with functionalized nanoparticles for cancer therapy: current and future perspectives

M Yadav, K Niveria, T Sen, I Roy, AK Verma - Nanomedicine, 2021 - clok.uclan.ac.uk
Apoptotic death evasion is a hallmark of cancer progression. In this context, past decades
have witnessed cytotoxic agents targeting apoptosis. However, owing to cellular defects in …

Targeting nonapoptotic pathways with functionalized nanoparticles for cancer therapy: current and future perspectives

M Yadav, K Niveria, T Sen, I Roy… - Nanomedicine …, 2021 - pubmed.ncbi.nlm.nih.gov
Apoptotic death evasion is a hallmark of cancer progression. In this context, past decades
have witnessed cytotoxic agents targeting apoptosis. However, owing to cellular defects in …

[PDF][PDF] Targeting non-apoptotic pathways with multifunctional nanoparticles for cancer therapy: Current and future perspectives

M Yadav, K Niveria, T Sen, I Roy, AK Verma - academia.edu
Apoptotic death evasion is a hallmark of cancer progression. In this context, past decades
have witnessed cytotoxic agents targeting apoptosis. However, owing to cellular defects in …

Targeting nonapoptotic pathways with functionalized nanoparticles for cancer therapy: current and future perspectives

M Yadav, K Niveria, T Sen, I Roy, AK Verma - Nanomedicine, 2021 - clok.uclan.ac.uk
Apoptotic death evasion is a hallmark of cancer progression. In this context, past decades
have witnessed cytotoxic agents targeting apoptosis. However, owing to cellular defects in …